Publication
Serologic follow-up in patients with multiple myeloma without repeated bone marrow studies: a single-institution experience.
Lidia Joanna Alberto-López, Oscar Emigdio Melchor-Melo, Miguel Ángel Gómez-Cabrera, José Rodrigo Velasco-Padilla, Juan Pablo Ramírez-García, Paola Andrea Anaya-Valdés, Sofía Chávez-Martínez, Max Robles-Nasta, Juan Carlos Olivares-Gazca, José María Moraleda, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Argüelles
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
INTRODUCTION: Assessment of measurable residual disease (MRD) in multiple myeloma (MM) often relies on repeated bone marrow evaluations, which are invasive, costly, and not universally accessible. Alternative monitoring approaches based on routinely available laboratory tests may provide clinically…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMultiple Myelomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available